Session Information
2009 BIO International Convention
Click here to go to the previous page
Mastering Your (Cell) Fate: Stem Cells, iPSCs and the Future of Medicine
Track : Drug Discovery and Development
Program Code: 2833
Date: Monday, May 18, 2009
Time: 2:00 PM to 3:30 PM  EST
Location: B309
SPEAKER (S):
Steven Burrill, Chief Executive Officer, Burrill & Company
Paul Grayson, Fate Therapeutics, Inc
Richard Gregory, PhD, Senior Vice President and Head of Corporate Research, Genzyme Corporation
Ian Ratcliffe, PhD, CEO, Stemgent, Inc.
Description
A series of important discoveries have illuminated the possibility of modulating cell fate for therapeutic purposes. Whether the aim is to regenerate or repair diseased or damaged tissue, produce personalized regenerative medicines, or create better drug development and research tools, the key is safe and effective modulation of cell fate. At this panel, the foremost researchers and executives leading the development of new technologies and medicines in cell fate modulation will discuss current approaches and explore future directions.

• Explore research breakthroughs that lead to the ability to modulate cell fate
• Highlight the progress of select development programs
• Discuss the path forward and commercial potential for the field


Audio Synchronized to PowerPoint
(Code: 2833)
  
This session is a part of: